XYNOMIC PHARMACEUTICALS HOLDINGS, INC. — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9f62f39c-3f04-45a2-844a-d74dccec168d/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-25.0M | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-013743 |
| FY 2018 | $-28.6M | 2018-01-01 – 2018-12-31 | evidence 0001213900-20-013743 |
| FY 2017 | $-365.2k | 2017-01-01 – 2017-12-31 | evidence 0001213900-18-002137 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. — all facts · Net Income